|
|
|
|
|
Teisinis statusas
Patentas galioja
| (51) | INT.CL. | A01N 41/06 | (2006.01) |
| A61K 31/18 | (2006.01) | ||
| C07D 403/12 | (2006.01) | ||
| C07D 413/14 | (2006.01) | ||
| C07D 213/73 | (2006.01) | ||
| C07D 231/20 | (2006.01) | ||
| C07D 401/04 | (2006.01) | ||
| C07D 235/24 | (2006.01) | ||
| C07D 403/10 | (2006.01) | ||
| C07D 239/34 | (2006.01) | ||
| C07D 407/12 | (2006.01) | ||
| C07D 209/18 | (2006.01) | ||
| C07D 209/49 | (2006.01) | ||
| C07D 213/64 | (2006.01) |
| (11) | Patento numeris | 3203840 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 15849396.5 |
| Europos patento paraiškos padavimo data | 2015-10-06 | |
| (97) | Europos patento paraiškos paskelbimo data | 2017-08-16 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2020-08-05 |
| (46) | Apibrėžties vertimo paskelbimo data | 2020-10-26 |
| (86) | Numeris | PCT/US2015/054316 |
| Data | 2015-10-06 |
| (87) | Numeris | WO 2016/057572 |
| Data | 2016-04-14 |
| (30) | Numeris | Data | Šalis |
| 201462060182 P | 2014-10-06 | US | |
| 201562114767 P | 2015-02-11 | US | |
| 201562153120 P | 2015-04-27 | US |
| (72) |
MILLER, Mark Thomas, US
ANDERSON, Corey, US
ARUMUGAM, Vijayalaksmi, US
BEAR, Brian Richard, US
BINCH, Hayley Marie, US
CLEMENS, Jeremy J., US
CLEVELAND, Thomas, US
CONROY, Erica, US
COON, Timothy Richard, US
FRIEMAN, Bryan A., US
GROOTENHUIS, Peter Diederik Jan, US
GROSS, Raymond Stanley, US
HADIDA-RUAH, Sara Sabina, US
KHATUYA, Haripada, US
JOSHI, Pramod Virupax, US
KRENITSKY, Paul John, US
LIN, Chun-Chieh, US
MARELIUS, Gulin Erdogan, US
MELILLO, Vito, US
MCCARTNEY, Jason, US
NICHOLLS, Georgia McGaughey, US
PIERRE, Fabrice Jean Denis, US
SILINA, Alina, US
TERMIN, Andreas P., US
UY, Johnny, US
ZHOU, Jinglan, US
|
| (73) |
Vertex Pharmaceuticals Incorporated,
50 Northern Avenue, Boston, MA 02210,
US
|
| (74) |
Jurga PETNIŪNAITĖ,
AAA Law, A. Goštauto g. 40B, Verslo centras "Dvyniai", LT-03163 Vilnius,
LT
|
| (54) | Cistinės fibrozės transmembraninio laidumo reguliatoriaus moduliatoriai |
| MODULATORS OF CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR |
| Mokėjimo data | Galiojimo metai | Suma | |
| 2025-09-18 | 11 | 289.00 EUR |
| 2026-10-06 |